SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027562
Filing Date
2021-05-13
Accepted
2021-05-13 16:16:16
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mtcr-10q_20210331.htm 10-Q 2040856
2 EX-10.1 mtcr-ex101_212.htm EX-10.1 67801
3 EX-31.1 mtcr-ex311_8.htm EX-31.1 20972
4 EX-31.2 mtcr-ex312_9.htm EX-31.2 19772
5 EX-32.1 mtcr-ex321_7.htm EX-32.1 14154
  Complete submission text file 0001564590-21-027562.txt   6589804

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mtcr-20210331.xml EX-101.INS 1305377
7 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20210331.xsd EX-101.SCH 47388
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtcr-20210331_cal.xml EX-101.CAL 46555
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtcr-20210331_def.xml EX-101.DEF 119263
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20210331_lab.xml EX-101.LAB 383546
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20210331_pre.xml EX-101.PRE 280594
Mailing Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121
Business Address 3985 SORRENTO VALLEY BLVD., SUITE C SAN DIEGO CA 92121 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39512 | Film No.: 21919852
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences